department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

adebrelimab · pharmadog

pharmadog
drugs
adebrelimab

drug

patient view →

adebrelimab

updated 2mo ago

by Jiangsu Hengrui Pharmaceuticals Co Ltd

community read0 votes

all catalysts(3)

phase 1 2 completion · 1

phase 1 2 completion

Jiangsu Hengrui Pharmaceuticals Co Ltd — adebrelimab (Phase I/II Trial Completion)

phase 2 completion · 2

phase 2 completion

Hospital Of Dalian Medical University 1 — adebrelimab (Phase II Trial Completion)

phase 2 completion

Nanfang Hospital of Southern Medical University — adebrelimab (Phase II Trial Completion)

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 6

tagOncology6 co-mentions · 3 sources
tagNSCLC3 co-mentions · 2 sources
tagPulmonology2 co-mentions · 2 sources
companyJiangsu Hengrui Pharmaceuticals Co Ltd1 co-mentions · 1 sources
companyHospital Of Dalian Medical University 11 co-mentions · 1 sources
companyNanfang Hospital of Southern Medical University1 co-mentions · 1 sources

Trials studying adebrelimab

phase2A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinomanot yet recruitingn=120
phase2A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumorsrecruitingn=156
phase2Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by TACE-HAICnot yet recruitingn=38
phase3Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancernot yet recruitingn=874
phase2Clinical Study of SHR-A1921 Combined With Adebrelimab and SHR-8068 With or Without Carboplatin in the Treatment of Advanced NSCLCwithdrawn
phase2A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancerrecruitingn=200
phase2Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinomrecruitingn=139
phase3A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancernot yet recruitingn=165

more trials →